Movie Industry

Even the author of the original "Intern" is cheering on the chemistry between Choi Min-sik and Han So-hee… "It's incredibly exciting"

The movie "The Intern" opens on the 16th

Choi Hee-jae
2026-09-03 17:43:20
[Edaily Starin Choi Hee-jae Reporter] Director Nancy Meyers, the creator of the original *The Intern*, expressed her anticipation for the Korean remake of *The Intern*.
(Photo courtesy of Warner Bros. Korea)

Director Nancy Meyers, who wrote and directed the original film “The Intern”—starring Robert De Niro and Anne Hathaway—which was a global box office hit in 2015 and is still considered by many to be one of their “all-time favorite movies”—has sent a special message of support for the Korean remake.
Set to open on the 16th, “The Intern” depicts office life that transcends both generations and job titles, beginning when “Ki-ho” (Choi Min-sik), a 37-year veteran “silver intern,” joins the company of “Seon-woo” (Han So-hee), who has rapidly risen to become a dark horse in the fashion industry just three years after launching her brand.
Veteran director Nancy Meyers, who has been active in Hollywood across various roles—including screenwriting, directing, and producing—for films such as *Romantic Holiday* and *Things We Ought to Let Go of When We Love*, expressed her special affection for the original film, saying, “It was a movie that began with my wish that there had been someone to quietly support me during my youth.”
She continued, “I was delighted to hear that it would be remade in Korea, and as a creator, I’m incredibly excited. It’s very meaningful that this story can resonate even across different cultures,” expressing her anticipation.
She also expressed her confidence in the lead actors, Choi Min-sik and Han So-hee. Regarding Choi Min-sik, who plays the silver intern “Ki-ho,” she said, “I was truly delighted to hear that Choi Min-sik, a leading figure in the Korean film industry, had been cast. I have high expectations that he will bring a depth, dignity, and charm distinct from Robert De Niro’s portrayal.”
Regarding Han So-hee, who plays the workaholic CEO “Seon-woo,” he added, “I believe she will charmingly portray the role of a confident, energetic, and modern leader. I’m already curious to see the special chemistry these two actors will showcase.”
Director Nancy Meyers addressed Korean audiences, saying, “I am always grateful to Korean audiences for their deep love of the original film.” She continued, “I hope you will find warm laughter and comfort in the Korean version of *The Intern* as well, and I sincerely hope it becomes a film that everyone will remember for a long time.”
“The Intern” is set to open in theaters in nine Asian countries—including Hong Kong, Indonesia, Malaysia, the Philippines, Singapore, Taiwan, Thailand, Vietnam, and Cambodia—on the 16th of next month. This marks the largest-scale Asian release of a Korean film ever presented by Warner Bros. Korea.
Kurt Leader, Head of Theatrical Distribution for Warner Bros. Asia-Pacific (APAC), said, “We are delighted to restart Warner Bros. Korea’s Korean film project with *The Intern*. We have very high expectations for introducing this IP, which has already been loved by countless audiences, to Korea in a new way.” He added, “Since Korean actors have offered a unique reinterpretation of director Nancy Meyers’ classic masterpiece, I hope fans in Korea and across Asia will thoroughly enjoy it.”
*The Intern* is directed by Kim Do-young, who previously helmed the film *If We*. The cast includes Choi Min-sik and Han So-hee, as well as Kim Jun-han, Ryu Hye-young, Kim Geum-soon, Park Ye-ni, Kim Yo-han, Im Sung-kyun, and Yoon Sang-jung. The film opens on the 16th of next month.

Economy

Corporation

IT·Science

Economy

Beyond Steel to High-Tech Industries… The Investment Landscape Is Changing

Domestic steel companies are expanding their reach into high-tech industries through corporate venture capital (CVC) investments. This move is intended to address the structural growth limitations the…
2026-09-03 21:22:04

IT·Science

AprilBio Co.,Ltd. Unveils Preclinical Data on Dual-Target RNAi… Accelerating Follow-Up Development

AprilBio Co.,Ltd. CI. (Photo courtesy of AprilBio Co.,Ltd.) AprilBio Co.,Ltd.(397030)has obtained early preclinical data for its dual-target RNA interference (RNAi) candidate. With a single adminis…
2026-09-03 18:15:03